Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers

Inclusion Criteria: * Healthy Japanese subjects * BMI (Body Mass Index) between 18.0-27.0 kg/m\^2 inclusive Exclusion Criteria: * Any clinical laboratory values deviated from the reference range at the laboratory (except for cases within physiological change) or any abnormal ECG (electrocardiogram) findings at the screening * Presence of diabetes, cancer or any clinically significant cardiac, respiratory, metabolic, renal, hepatic, gastrointestinal, endocrinological, dermatological, venereal, haematological, neurological, or psychiatric diseases or disorders * Hepatitis B surface antigen, Hepatitis C antibodies or HIV (human immunodeficiency virus) antibodies positive * History of diabetes, cancer or any clinically significant cardiac, respiratory, metabolic, renal, hepatic, gastrointestinal, endocrinological, dermatological, venereal, haematological, neurological, or psychiatric diseases or disorders * History of significant allergy or hypersensitivity * Known or suspected allergy to trial product or related products * History of drug or alcohol abuse * The subjects who smoke more than 15 cigarettes, or the equivalent, per day and is unwilling to refrain from smoking whenever required for the trial procedure